Purpose: To evaluate the short-and long-term outcomes of hybrid repair of the arch and proximal descending aorta in a single tertiary center for aortic disease. Methods: A retrospective analysis was performed of 55 patients (median age 67 years; 36 men) who underwent hybrid repair of thoracic aortic pathology with involvement of the arch between January 2005 and May 2015 at a single tertiary center. The pathologies included 40 (73%) with aneurysmal disease, 10 (18%) acute type B aortic dissections, 2 with acute aortic syndrome, an acute type A dissection, and left and aberrant right subclavian artery aneurysms. Seven (13%) procedures were performed as an emergency. Demographics and procedure characteristics were collected for analysis of survival and reinterventions. Results: Complete aortic debranching was performed in 14 (25%) to facilitate endograft placement in zone 0; debranching was partial in 20 (36%) patients for zone 1 deployments and 21 (38%) for zone 2. Primary technical success was achieved in 51 (93%) cases. One patient died in-hospital from aneurysm rupture following aortic debranching prior to stent-graft repair. In another, the stent-graft procedure proved infeasible and was abandoned. The other 2 technical failures were due to type Ia endoleaks. Five (9%) patients died in-hospital (4 of 48 elective and 1 of 7 emergency cases); 2 of these patients died within 30 days (4%). Eight (14%) patients had a stroke, 6 of 48 elective and 2 of the 7 emergency patients. Spinal cord ischemia was reported in 3 (6%) patients. Mean follow-up was 74.6 months. Overall cumulative survival was 70% at 1 year, 68% at 2 years, and 57% at 5 years. Reintervention to the proximal landing zone for type Ia endoleak was required in 6% of cases. The overall rate of aortic reintervention was 18% at 1 year, 21% at 2 years, and 36% at 5 years. Overall extra-anatomic graft patency was 99%. Conclusion: Hybrid repair of the aortic arch and proximal descending thoracic aorta is technically feasible, with acceptable short-term mortality. There is a low rate of proximal landing zone reintervention when hybrid techniques are used to create an adequate proximal landing zone. Extra-anatomic bypass grafts have good long-term patency. Ongoing disease progression means that further distal aortic interventions are often necessary in patients with extensive disease.
Introduction
Traditional open approaches to the management of disease of the aortic arch and proximal descending thoracic aorta are associated with significant morbidity and mortality, particularly in high-risk patients as the need for circulatory arrest is not well tolerated in this group. [1] [2] [3] [4] [5] Endovascular treatment of thoracic aortic pathologies is a well-established surgical technique with superior short-term outcomes when compared with open approaches, but it is limited by the need for adequate seal and fixation. [6] [7] [8] [9] First described in 1998, 10 the hybrid arch technique utilizes thoracic endovascular aortic repair (TEVAR) together with supra-aortic debranching to extend the proximal landing zone. This technique facilitates long-term fixation and adequate seal of the endograft and is a viable alternative to aid in the treatment of complex pathologies that extend across the aortic arch. [11] [12] [13] [14] The evolution of endovascular technology has meant that total endovascular approaches to the treatment of the aortic arch are now available; however, this technology is still in its infancy and requires further evaluation, particularly with regard to feasibility, stroke rates, long-term outcomes, and durability. [15] [16] [17] Continuing our work with the hybrid management of complex diseases of the aortic arch and descending thoracic aorta, 18 the current report provides an assessment of long-term outcomes in a larger cohort.
Methods

Study Design
A retrospective review was performed of a prospectively collected departmental database from a tertiary referral center for complex arch and thoracoabdominal aortic disease. Consecutive patients who underwent emergency or elective hybrid repair for thoracic aortic pathology with involvement of the arch between January 2005 and May 2015 were identified. Patients operated on for aortic arch aneurysms, thoracic aortic aneurysms, thoracoabdominal aortic aneurysms (TAAA, types I and II), aortic dissection (acute and chronic, types A and B), and acute aortic syndrome [intramural hematoma (IMH) and penetrating aortic ulcer (PAU)] were eligible for analysis, as were patients with underlying connective tissue disorders and those who had previously undergone aortic intervention, including root replacement, coarctation repair, and additional interventions to the distal aorta either before or after their hybrid procedure. Patients undergoing open repair, operations combined with other major procedures, and those with a scallop or single branched device for the left subclavian artery (LSA) were excluded. Data were collected on patient demographics, significant comorbidities, aortic pathology, indication for intervention, procedure characteristics, short-term outcomes, and long-term follow-up based on suggested minimum pragmatic reporting standards for TEVAR. 19 The Ishimaru classification was used to categorize the proximal landing zones for stent-graft deployment. 20 
Patient Population
The search identified 55 patients (median 67 years; 36 men) who met the inclusion criteria for the analysis. Preoperative patient characteristics and procedural information are described in Table 1 . The overwhelming majority of patients (48, 87%) were classified as American Society of Anesthesiologists (ASA) grade III or IV at the time of surgery. Eighteen (25%) patients had had previous aortic surgery, the majority either for type A aortic dissection or coarctation repair. Three (5%) patients had a history of known connective tissue disorders, and all had had previous aortic surgery.
Twenty-eight (51%) patients were treated for symptomatic disease, 7 (13%) as an emergency within 24 hours of symptom onset. The pathologies included aneurysmal disease (40, 73%), 10 (18%) acute type B aortic dissections, and an acute type A dissection in a patient deemed too high risk for open surgery. Four patients had PAU/IMH (2 cases), an aberrant right subclavian artery aneurysm, and a LSA aneurysm. In the 40 patients with aneurysmal disease, 15 (37%) had aneurysmal dilatation of the false lumen in chronic type B aortic dissection, and 5 (12%) were paraanastomotic in the setting of a previous coarctation repair.
Surgical Techniques
The technique was performed as a single procedure or, preferably, as a staged repair wherever feasible to reduce the perioperative risks associated with debranching and spinal cord ischemia (SCI) when extensive coverage of the thoracic aorta was planned. For extra-anatomic reconstruction in patients requiring stent-graft placement in zone 2, a left carotid-subclavian bypass graft was performed through a left supraclavicular incision, together with ligation or embolization of the LSA proximal to the vertebral artery origin. Alternatively, LSA transposition was performed through the same approach in a minority of patients. For patients requiring stent-graft placement in zone 1, a carotid-carotid bypass graft was performed, tunneled anteriorly or, more recently, via a retroesophageal approach. A separate carotid subclavian bypass or an extension of the carotid-carotid bypass to the subclavian vessel was also used in these patients, and the proximal left carotid artery was also ligated or embolized.
For those patients requiring placement of the stent-graft in zone 0, neo-innominate reconstruction was performed through a median sternotomy, utilizing a side-biting clamp on the aorta. A variety of graft configurations can be used in this procedure, but the most common was a 10-mm Dacron graft from the ascending aorta to the innominate artery, an 8-mm graft from this to the left common carotid artery (LCCA), and a left carotid-subclavian bypass in the neck. Examples of these debranching procedures are shown in Figure 1 .
With the patient heparinized, the endograft was delivered via the common femoral artery or an iliac conduit when there were diseased or small external iliac vessels. Contralateral femoral access was usually used for the pigtail imaging catheter. Selective spinal cord protection with drain insertion was used depending on patient factors, for example, concurrent anticoagulation therapy, previous aortic surgery, and the intended aortic coverage length. For device deployment in zone 2, drug-induced hypotension was established to reduce maldeployment; for deployment in zones 0 and 1, overdrive cardiac pacing was employed to ensure accurate graft placement.
The standard follow-up protocol consisted of computed tomography angiography (CTA) of the entire aorta and supra-aortic vessels at 4 weeks postoperatively, with annual CT imaging thereafter unless clinically indicated at an earlier time. Annual duplex ultrasound surveillance of the extra-anatomic bypass grafts was also performed. In addition, patients were reviewed on a regular basis within the outpatient setting either at our unit or at their local hospital with subsequent review of their CTA at our multidisciplinary team meeting.
Definitions, Outcomes, and Statistical Analysis
Primary technical success was defined as completed supraaortic reconstruction, together with satisfactory deployment of the stent-graft with no type I or III endoleak, retrograde type A dissection, stent collapse or deformation, stent migration during deployment, or conversion to an open procedure.
Primary outcome measures were technical success and mortality (in-hospital and 30-day). In-hospital morbidity (ie, stroke, SCI, and surgical reintervention) were analyzed. In follow-up, data were collected on all-cause mortality, endoleak, and reintervention. Long-term outcome data were collected from medical records and validated via the National Health Service (NHS) Spine, part of the NHS Care Records Service managed by the Health & Social Care Information Centre.
Continuous data are presented as the means and 95% confidence intervals (CI) or medians and absolute range; categorical data are given as the counts (percentage). In addition, Kaplan-Meier estimates were generated to describe survival and reintervention-free survival. Statistical analysis was performed with SPSS 22 for Mac software (IBM Corporation, Somers, NY, USA). 
Results
Complete aortic debranching to facilitate a proximal landing within zone 0 was performed in 14 (25%) patients (Table 2) , of which 2 had stent-grafts inserted with either a fenestration or scallop for the innominate artery. Partial debranching was performed in 20 (36%) patients for zone 1 landing zones and 21 (38%) for zone 2. Overall, 42 (76%) patients had LSA revascularization through either a LCCA-LSA bypass or LSA transposition. Thirty-two (58%) cases were performed as a single procedure. In the 23 (42%) staged procedures, aortic debranching was performed a median 18 days (range 2-259) prior to stent insertion. Forty (73%) patients had a spinal drain placed.
Early Outcomes
Primary technical success was achieved in 51 (93%) of 55 cases. One staged patient died following an uncomplicated debranching procedure (RCCA-LCCA bypass) as a result of spontaneous aneurysm rupture 6 days postoperatively. In a zone 2 case, following transposition of the LSA, the TEVAR procedure had to be abandoned due to an inability to safely advance the stent-graft system through tortuous and complex iliac artery anatomy. The other 2 failures were due to type Ia endoleaks seen on completion angiography; one was successfully managed with a proximal cuff extension and chimney graft to the innominate artery, and the other was untreated due to the patient's deteriorating clinical condition. A mean of 2.5 (range 1-9) aortic stent-grafts were placed in 53 patients, depending on pathology and length of aortic coverage required for primary technical success. No conversion to open surgical arch repair was required in any of the cases performed.
Mortality. Five (9%) patients died in-hospital (4 of 48 elective and 1 of 7 emergency cases); 2 of these patients died within 30 days (4%). One patient with a ruptured 5.6-cm arch aneurysm died 11 days after sustaining an intraoperative myocardial infarction (MI) and stroke in an emergency complete debranching and TEVAR, together with laparotomy and thrombectomy of an occluded bypass graft placed for a previous infrarenal abdominal aneurysm (to facilitate stent-graft placement). The other 30-day death was the patient who died of TAAA rupture 6 days after her elective debranching procedure, as previously discussed.
Of the 3 other in-hospital deaths, 1 occurred in a patient with a 7.6-cm type II TAAA who underwent a staged zone 0 hybrid repair followed by a 4-vessel visceral hybrid procedure that was complicated by a relook laparotomy for abdominal compartment syndrome. He died 65 days after the initial arch procedure due to multiorgan failure (MOF). Another patient with a 7.5-cm type I TAAA suffered an intraoperative stroke and died of MOF 70 days after an elective zone 0 hybrid repair. The final in-hospital death involved a patient with a 7.9-cm type I thoracoabdominal aneurysmal dilatation of a chronic type B dissection. He succumbed 159 days after an elective zone 1 hybrid repair secondary to complications from an intraoperative MI.
Morbidity. Eight (14%) patients had a stroke following their procedure, 6 of 48 elective and 2 of the 7 emergency patients. Three (6%) of the 53 patients who had an endograft placed suffered SCI with new-onset permanent motor, sensory, or combined deficits.
Reinterventions and Endoleaks. Sixteen (29%) patients required a secondary procedure during the hospital admission. Eight had complications related to the extra-anatomic bypass grafts: 5 were treated for bleeding or hematoma and a further 3 required thromboembolectomy for acute graft occlusion. Four patients with early endoleaks identified on CT prior to discharge required a reintervention. One patient had a type Ia endoleak that was treated successfully with a proximal cuff extension and chimney graft to the innominate artery. A type Ib endoleak was successfully treated with a distal cuff extension, and 2 patients required LSA embolization to treat type II endoleaks. A further 2 patients developed early type II endoleaks that were not treated prior to discharge. The overall early endoleak rate was 11% (6/55). Of the remaining 4 patients who had reinterventions during their hospital admission, one required a bronchial stent for obstruction secondary to external compression by a large aneurysm sac. One patient fell on the ward postoperatively, sustaining a fractured femur requiring surgical fixation and a prolonged hospital stay. Two patients who had staged hybrid arch and visceral hybrid procedures required re-laparotomy for complications resulting from the visceral hybrid procedure (bowel ischemia and bilateral renal graft occlusion). 
Long-term Outcomes
Overall mean follow-up was 74.6 months (95% CI 57.5 to 91.7): 77.0 months (95% CI 58.5 to 95.4) and 41.7 months (95% CI 8.2 to 75.3) in the elective and emergency groups, respectively. Overall cumulative survival estimates ( Figure  2A ) were 70% at 1 year, 68% at 2 years, and 57% at 5 years.
Overall cumulative survival estimates in the elective cohort were 71%, 71%, and 58% at the same time intervals. In the 7 emergency cases, follow-up beyond 1 year was limited; 3 of 7 patients were alive at 1 year. Overall aortic reintervention estimates by Kaplan-Meier analysis ( Figure 2B ) were 18% at 1 year, 21% at 2 years, and 36% at 5 years. Reintervention to the proximal landing zone for late Ia endoleak was minimal, with only 2 patients requiring intervention during follow-up. Including the single early proximal type I endoleak, the reintervention rate to the proximal landing zone was 6% (3/53). Reintervention to the distal aorta was more common, with cumulative reintervention estimates of 18% at 1 year, 22% at 2 years, and 30% at 5 years. Overall, there were 6 type Ib endoleaks, 6 type II endoleaks, and 2 type III endoleaks that required intervention. A further 3 type II endoleaks and a type Ib endoleak identified during follow-up did not require intervention during that period.
Seven of 55 patients required subsequent procedures to treat aneurysmal dilatation distal to their arch endograft without endoleak: 4 visceral hybrid procedures, 2 open aneurysm repairs, and 1 endovascular aneurysm repair. One patient required a redo aortic root repair following development of a pseudoaneurysm proximal to the arch endograft. One patient developed a graft infection 5 months after stentgraft placement.
A total of 79 extra-anatomic grafts were placed in the patient cohort. Over follow-up, a single LCCA-LSA graft occluded (99% long-term extra-anatomic bypass graft patency).
Discussion
Repair of diseases of the arch is a significant undertaking and should not be embarked upon lightly. It has been suggested that as little as 12% of patients undergoing hybrid arch repair are suitable for an open repair, due to the presence of either multisegmental aortic disease or other significant comorbidities. 21 This study has demonstrated that hybrid arch repair is a feasible technique for tackling challenging arch pathologies. Our overall 4% 30-day mortality compares favorably to other similar case series (range 1.6%-25%). It is important to note the difference in 30-day death rates between our elective and emergency patients was due not only to discrepancy in sample sizes but also to differences in the condition of the patient at the time of surgery and the need to perform a single stage procedure in emergency cases. 22 The perioperative rates of stroke (14%) and SCI (6%) are also comparable to those previously reported in similar patients undergoing hybrid, open, and total endovascular procedures. [11] [12] [13] 21, 23, 24 Cumulative survival was lower (70% at 1 year) than in straightforward TEVAR cases, which have a cumulative survival of ~80% over the same time frame. 25 This is to be expected given the more extensive disease states in our patients. Our outcomes to 5 years are very favorable for such a diseased cohort, particularly when compared to the 1-year rate. Focusing on improving short-term survival, specifically in the high risk emergent cases, may enhance long-term results in the future. However, the low 1-year survival in the emergency group highlights the importance of understanding the risks attending these extensive procedures, which may lead to early mortality and morbidity.
Primary technical success was high (93%) and the early type Ia endoleak rate relatively low (6%). Previous series have documented pooled rates of 11% to 16%. 21, 23 This low rate of proximal landing zone primary failure may be a result of our deliberate effort to achieve a landing zone of suitable length and quality in the proximal aorta. The results of this study may suggest that surgeons should extend their landing zone proximally into zones 0/1 if there is doubt as to the suitability of landing in zones 2/3. The concern for type A retrograde dissection is warranted, and some studies have reported a rate of up to 6.5% with endografts deployed in the native aorta. 26 However, we encountered no cases of this sequela in our cohort.
In general, arch disease patients are deemed unfit or unsuitable for traditional open surgery and are believed to be at significantly lower risk from endovascular or hybrid approaches while accepting a greater likelihood of long-term reintervention. Our cumulative aortic reintervention estimates to 5 years (36%) are comparable to rates across a broad range of aortic procedures in both the thoracic and abdominal aorta. 27, 28 Only 6% of patients required a reintervention to the proximal landing zone during follow-up, demonstrating the durability and long-term success that is achievable if adequate fixation and sealing is obtained at the time of the first procedure. As a general principle, we accept a 2-cm parallel wall landing zone, except in those with significant angulation of the arch where a shorter, lower quality landing zone may be tolerated. The quality of the achievable landing zone is paramount in decision making, with a more proximal landing zone likely to be more stable and durable. The lower late endoleak rate due to the less hostile aortic morphology justifies the use of a hybrid approach.
A quarter of the patients developed type Ib, II, or III endoleaks, and open or endovascular treatment to the diseased aorta distal to the thoracic stent-graft was required in 7 (13%) patients. This high reintervention rate to the distal aorta, secondary to either type Ib endoleak or distal aneurysmal degeneration, is without doubt due to the ongoing disease process.
Both the overall 30-day and in-hospital mortalities of our cohort are favorable compared with data from a traditional open approach. Utilization of adjunctive measures for cerebral protection, such as profound hypothermia, circulatory arrest, and retrograde cerebral perfusion, have been shown to improve the results of open surgery to a point where the mortality, stroke, and reintervention rates in the midterm are comparable to those of an endovascular approach. This must, however, be seen in the context of the younger, healthier, and generally lower risk population undergoing open procedures. 5, 29 These new adjunctive techniques may, however, also provide important lessons and insights into improving shorter-term outcomes in the hybrid arch repair population, a key focus for the future.
In addition to hybrid arch repair, total endovascular approaches to the arch have been utilized. Chimney grafts have achieved comparable mortality and stroke rates to that of hybrid repair; however, the use of chimneys is associated with a significant type Ia endoleak rate of 15% to 18% compared to the 6% reported in our cohort. 30, 31 This high rate of endoleak is likely due to the presence of wide gutters associated with the chimneys grafts, which may be reduced by using balloon-expandable covered stents. 31 More recently, a total endovascular approach to the arch utilizing branched endografts has been described as a feasible alternative, 17 although it is still in its infancy compared to hybrid and open solutions. Early evidence suggests that total endovascular repair performs adequately in terms of primary technical success and 30-day mortality after the learning curve is mastered. 15, 16 A total endovascular approach to the arch certainly has a role to play in selected patients with difficult pathologies; however, the current paucity of literature and evidence, particularly in terms of its durability as a technique, makes it difficult to directly compare to either hybrid arch or open repair at present.
The current evidence suggests that relatively high-risk patients have acceptable mortality and morbidity outcomes from a hybrid approach to the arch compared to open surgery or a total endovascular repair as the technology stands at present. Further evidence is required to compare the techniques in the long term, specifically in important areas such as durability and cost-effectiveness, although some evidence suggests that TEVAR is the more cost-effective option even when the expenses associated with surveillance imaging and reintervention are included. 32 
Limitations
While providing good evidence for the applicability, feasibility, and durability of hybrid arch repair, the results presented here are not without limitations. This single-center cohort was certainly affected by patient selection bias, the surgical and interventional strategies adopted, and nuances of local referral and individual practice. In addition, the patients were a heterogeneous group of disease processes, anatomy, and surgical approaches to treatment. As with any cohort series, difficulties with follow-up and data collection were present, and there were limited numbers of patients with a follow-up past 3 years from which to draw firm conclusions. Finally, as has been discussed, complex aortic arch pathologies have a range of treatment options, from conventional open surgery through to total endovascular approaches, all of which come with their own advantages and disadvantages. Given that the groups selected for open surgery and for endovascular approaches are likely to be significantly different in terms of comorbidity and anatomical suitability for stenting, no attempt was made to compare the 2 techniques in the series.
Conclusion
Hybrid repair of the aortic arch and proximal descending thoracic aorta is a technically feasible technique for tackling challenging aortic pathologies, with acceptable success rates and 30-day mortality. Longer-term outcomes are good, but the focus should be on improving early outcomes, particularly in the emergent patient. There is a low rate of proximal landing zone reintervention when hybrid techniques are used to create an adequate proximal landing zone, and extra-anatomic bypass grafts have an extremely good longterm patency rate.
A policy of endograft placement into landing zones extended by extra-anatomic revascularization appears to provide a robust seal and requires few subsequent interventions at this site. Despite this, the ongoing degenerative disease of the aorta means that further distal intervention is often necessary in this cohort of patients. While traditional open techniques currently remain the standard of care for young fit patients, the technique can be associated with significant morbidity and mortality, especially in high-risk comorbid patients. The hybrid approach to the arch is an option in patients unfit for open surgery and in those anatomically unsuitable for a totally endovascular approach.
